CAMG
BIIB icon

CWA Asset Management Group’s Biogen BIIB Stock Holding History

CWA Asset Management Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.24M Buy
38,127
+3,297
+9% +$631K 0.25% 86
2026
Q1 		$6.39M Buy
34,830
+2,296
+7% +$423K 0.22% 104
2025
Q4 		$5.73M Buy
32,534
+2,841
+10% +$464K 0.21% 102
2025
Q3 		$4.16M Buy
29,693
+3,082
+12% +$417K 0.15% 134
2025
Q2 		$3.34M Buy
26,611
+4,143
+18% +$516K 0.14% 140
2025
Q1 		$3.07M Buy
+22,468
New +$3.21M 0.15% 139

Other funds holding BIIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

CWA Asset Management Group's BIIB Position: Q2 2026 in Review

CWA Asset Management Group increased its Biogen (BIIB) stake by 9.5% in Q2 2026, buying an estimated $631K and bringing the position to 38,127 shares worth $8.24M. The position accounts for 0.25% of the portfolio, ranked #86.

CWA Asset Management Group first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. 456 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • CWA Asset Management Group held 38,127 shares of Biogen worth $8.24M as of Q2 2026.
  • CWA Asset Management Group bought 3,297 Biogen shares in Q2 2026, an estimated $631K.
  • Biogen made up 0.25% of CWA Asset Management Group's portfolio in Q2 2026, its #86 holding.
  • CWA Asset Management Group first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
  • 456 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.